Eisner Mark 4
4 · Vir Biotechnology, Inc. · Filed Jul 16, 2024
Insider Transaction Report
Form 4
Eisner Mark
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2024-07-15+75,000→ 75,000 total - Award
Stock Option (Right to Buy)
2024-07-15+150,000→ 150,000 totalExercise: $9.37Exp: 2034-07-14→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on July 15, 2025, and the remainder vest in 36 equal monthly installments thereafter.